Endothelial dysfunction and vascular disease–a 30th anniversary update

PM Vanhoutte, H Shimokawa, M Feletou… - Acta …, 2017 - Wiley Online Library
The endothelium can evoke relaxations of the underlying vascular smooth muscle, by
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …

Vascular toxicities of cancer therapies: the old and the new–an evolving avenue

J Herrmann, EH Yang, CA Iliescu, M Cilingiroglu… - Circulation, 2016 - Am Heart Assoc
Since the late 1990s, there has been a steady decline in cancer-related mortality, in part
related to the introduction of so-called targeted therapies. Intended to interfere with a specific …

Hypertension and prohypertensive antineoplastic therapies in cancer patients

DCH Van Dorst, SJH Dobbin, KB Neves… - Circulation …, 2021 - Am Heart Assoc
The development of a wide range of novel antineoplastic therapies has improved the
prognosis for patients with a wide range of malignancies, which has increased the number …

Endothelial dysfunction and vascular disease

PM Vanhoutte, H Shimokawa, EHC Tang… - Acta …, 2009 - Wiley Online Library
The endothelium can evoke relaxations (dilatations) of the underlying vascular smooth
muscle, by releasing vasodilator substances. The best characterized endothelium‐derived …

Hydroethidine-and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth

J Zielonka, B Kalyanaraman - Free Radical Biology and Medicine, 2010 - Elsevier
Hydroethidine (HE; or dihydroethidium) is the most popular fluorogenic probe used for
detecting intracellular superoxide radical anion. The reaction between superoxide and HE …

The proteasomal system

T Jung, B Catalgol, T Grune - Molecular aspects of medicine, 2009 - Elsevier
Rising interest in the mechanism and function of the proteasomes and the ubiquitin system
revealed that it is hard to find any aspect of the cellular metabolic network that is not directly …

Protein damage, repair and proteolysis

N Chondrogianni, I Petropoulos, S Grimm… - Molecular aspects of …, 2014 - Elsevier
Proteins are continuously affected by various intrinsic and extrinsic factors. Damaged
proteins influence several intracellular pathways and result in different disorders and …

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review

G Georgiopoulos, N Makris, A Laina, F Theodorakakou… - Cardio Oncology, 2023 - jacc.org
Proteasome inhibitors (PIs) are the backbone of combination treatments for patients with
multiple myeloma and AL amyloidosis, while also indicated in Waldenström's …

Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel …

JR Pickett, Y Wu, LF Zacchi, HT Ta - Cardiovascular Research, 2023 - academic.oup.com
Vascular cell adhesion molecule-1 (VCAM-1) has been well established as a critical
contributor to atherosclerosis and consequently as an attractive therapeutic target for anti …

Proteasome inhibitor-related cardiotoxicity: mechanisms, diagnosis, and management

P Wu, O Oren, MA Gertz, EH Yang - Current oncology reports, 2020 - Springer
Abstract Purpose of Review Multiple myeloma is the second most common hematologic
malignancy in the USA, with over 32,000 new cases and nearly 13,000 deaths expected in …